These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21416055)

  • 1. Targeting transcription factor Stat5a/b as a therapeutic strategy for prostate cancer.
    Liao Z; Nevalainen MT
    Am J Transl Res; 2011 Feb; 3(2):133-8. PubMed ID: 21416055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer.
    Gu L; Liao Z; Hoang DT; Dagvadorj A; Gupta S; Blackmon S; Ellsworth E; Talati P; Leiby B; Zinda M; Lallas CD; Trabulsi EJ; McCue P; Gomella L; Huszar D; Nevalainen MT
    Clin Cancer Res; 2013 Oct; 19(20):5658-74. PubMed ID: 23942095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo.
    Dagvadorj A; Kirken RA; Leiby B; Karras J; Nevalainen MT
    Clin Cancer Res; 2008 Mar; 14(5):1317-24. PubMed ID: 18316550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal transducer and activator of transcription 5A/B in prostate and breast cancers.
    Tan SH; Nevalainen MT
    Endocr Relat Cancer; 2008 Jun; 15(2):367-90. PubMed ID: 18508994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.
    Tan SH; Dagvadorj A; Shen F; Gu L; Liao Z; Abdulghani J; Zhang Y; Gelmann EP; Zellweger T; Culig Z; Visakorpi T; Bubendorf L; Kirken RA; Karras J; Nevalainen MT
    Cancer Res; 2008 Jan; 68(1):236-48. PubMed ID: 18172316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer.
    Talati PG; Gu L; Ellsworth EM; Girondo MA; Trerotola M; Hoang DT; Leiby B; Dagvadorj A; McCue PA; Lallas CD; Trabulsi EJ; Gomella L; Aplin AE; Languino L; Fatatis A; Rui H; Nevalainen MT
    Am J Pathol; 2015 Sep; 185(9):2505-22. PubMed ID: 26362718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transducer and activator of transcription 5a/b: biomarker and therapeutic target in prostate and breast cancer.
    Koptyra M; Gupta S; Talati P; Nevalainen MT
    Int J Biochem Cell Biol; 2011 Oct; 43(10):1417-21. PubMed ID: 21704724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolactin receptor targeting in breast and prostate cancers: New insights into an old challenge.
    Goffin V
    Pharmacol Ther; 2017 Nov; 179():111-126. PubMed ID: 28549597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway.
    Dagvadorj A; Collins S; Jomain JB; Abdulghani J; Karras J; Zellweger T; Li H; Nurmi M; Alanen K; Mirtti T; Visakorpi T; Bubendorf L; Goffin V; Nevalainen MT
    Endocrinology; 2007 Jul; 148(7):3089-101. PubMed ID: 17412813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells.
    Dagvadorj A; Tan SH; Liao Z; Xie J; Nurmi M; Alanen K; Rui H; Mirtti T; Nevalainen MT
    Int J Biochem Cell Biol; 2010 Dec; 42(12):2037-46. PubMed ID: 20854925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Stat5a/b Enhances Proteasomal Degradation of Androgen Receptor Liganded by Antiandrogens in Prostate Cancer.
    Hoang DT; Gu L; Liao Z; Shen F; Talati PG; Koptyra M; Tan SH; Ellsworth E; Gupta S; Montie H; Dagvadorj A; Savolainen S; Leiby B; Mirtti T; Merry DE; Nevalainen MT
    Mol Cancer Ther; 2015 Mar; 14(3):713-26. PubMed ID: 25552366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT5a/b Deficiency Delays, but does not Prevent, Prolactin-Driven Prostate Tumorigenesis in Mice.
    Boutillon F; Pigat N; Sala LS; Reyes-Gomez E; Moriggl R; Guidotti JE; Goffin V
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31269779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair.
    Maranto C; Udhane V; Hoang DT; Gu L; Alexeev V; Malas K; Cardenas K; Brody JR; Rodeck U; Bergom C; Iczkowski KA; Jacobsohn K; See W; Schmitt SM; Nevalainen MT
    Clin Cancer Res; 2018 Apr; 24(8):1917-1931. PubMed ID: 29483142
    [No Abstract]   [Full Text] [Related]  

  • 14. STAT5A/B gene locus undergoes amplification during human prostate cancer progression.
    Haddad BR; Gu L; Mirtti T; Dagvadorj A; Vogiatzi P; Hoang DT; Bajaj R; Leiby B; Ellsworth E; Blackmon S; Ruiz C; Curtis M; Fortina P; Ertel A; Liu C; Rui H; Visakorpi T; Bubendorf L; Lallas CD; Trabulsi EJ; McCue P; Gomella L; Nevalainen MT
    Am J Pathol; 2013 Jun; 182(6):2264-75. PubMed ID: 23660011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
    Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
    Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancer.
    Gu L; Zhu XH; Visakorpi T; Alanen K; Mirtti T; Edmonston TB; Nevalainen MT
    Anal Cell Pathol (Amst); 2010; 33(2):55-9. PubMed ID: 20966544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia.
    Liao Z; Gu L; Vergalli J; Mariani SA; De Dominici M; Lokareddy RK; Dagvadorj A; Purushottamachar P; McCue PA; Trabulsi E; Lallas CD; Gupta S; Ellsworth E; Blackmon S; Ertel A; Fortina P; Leiby B; Xia G; Rui H; Hoang DT; Gomella LG; Cingolani G; Njar V; Pattabiraman N; Calabretta B; Nevalainen MT
    Mol Cancer Ther; 2015 Aug; 14(8):1777-93. PubMed ID: 26026053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth.
    Gu L; Dagvadorj A; Lutz J; Leiby B; Bonuccelli G; Lisanti MP; Addya S; Fortina P; Dasgupta A; Hyslop T; Bubendorf L; Nevalainen MT
    Am J Pathol; 2010 Apr; 176(4):1959-72. PubMed ID: 20167868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
    Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy.
    Mirtti T; Leiby BE; Abdulghani J; Aaltonen E; Pavela M; Mamtani A; Alanen K; Egevad L; Granfors T; Josefsson A; Stattin P; Bergh A; Nevalainen MT
    Hum Pathol; 2013 Mar; 44(3):310-9. PubMed ID: 23026195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.